Article
Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
BMC cancer - 20 Dec 2021
Olsen Maria, Fischer Krista, Bossuyt Patrick M, Goetghebeur Els
Abstract excerpt
BACKGROUND: Polygenic risk scores (PRS) could potentially improve breast cancer screening recommendations. Before a PRS can be considered for implementation, it needs rigorous evaluation, using performance measures that can inform about its future clinical value. OBJECTIVES: To evaluate the prognostic performance of a regression model with a previously developed, prevalence-based PRS and age as predictors for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
